Cutaneous Melanoma — Trials

Cutaneous Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

241 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 78
Recruiting: 39
Ph III recruiting: 3
Growth YoY: —
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.1%
Trials / 1,000 deaths: 9.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (42)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07068074	Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma	recruiting	Phase 3	428	ECOG-ACRIN Cancer Research GroupNETWORK	1	Sep 24, 2026	clinicaltrials
NCT06624644	A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma	recruiting	Phase 2 / Phase 3	135	Linnaeus Therapeutics, Inc.INDUSTRY	1	Apr 22, 2026	clinicaltrials